Management of rare coagulation disorders in 2018.

[1]  É. Katona,et al.  Auto‐ and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences , 2018, Journal of thrombosis and haemostasis : JTH.

[2]  Esther S. Kim,et al.  Emicizumab-kxwh: First Global Approval , 2018, Drugs.

[3]  M. Franchini,et al.  Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia , 2017, Seminars in Thrombosis and Hemostasis.

[4]  G. Kenet,et al.  Primary prophylaxis for children with severe congenital factor VII deficiency - Clinical and laboratory assessment. , 2017, Blood cells, molecules & diseases.

[5]  J. Oldenburg,et al.  Emicizumab Prophylaxis in Hemophilia A with Inhibitors , 2017, The New England journal of medicine.

[6]  A. Akinc,et al.  Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy , 2017, The New England journal of medicine.

[7]  H. Li,et al.  Genetic diagnosis in Hemophilia A from southern China: five novel mutations and one preimplantation genetic analysis , 2017, International journal of laboratory hematology.

[8]  G. Castaman,et al.  Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders , 2017, Journal of clinical medicine.

[9]  J. Huntington,et al.  Design and characterization of an APC-specific serpin for the treatment of hemophilia. , 2017, Blood.

[10]  B. Kerlin,et al.  Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes , 2016, Seminars in Thrombosis and Hemostasis.

[11]  F. Peyvandi,et al.  Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disorders. , 2016, Thrombosis research.

[12]  J. Peterson,et al.  Targeting TFPI for hemophilia treatment. , 2016, Thrombosis research.

[13]  A. Shirdel,et al.  Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial , 2016, Journal of thrombosis and haemostasis : JTH.

[14]  R. Kulkarni.  Improving care and treatment options for women and girls with bleeding disorders , 2015, European journal of haematology.

[15]  U. Martinowitz,et al.  The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency. , 2015, Thrombosis research.

[16]  S. Borrego,et al.  Experience of Preimplantation Genetic Diagnosis for Hemophilia at the University Hospital Virgen Del Rocío in Spain: Technical and Clinical Overview , 2015, BioMed research international.

[17]  M. Borhany,et al.  A new report of FVII‐inhibitor in a patient suffering from severe congenital FVII deficiency , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[18]  S. Milstein,et al.  An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia , 2015, Nature Medicine.

[19]  S. Lethagen,et al.  Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial , 2015, Journal of thrombosis and haemostasis : JTH.

[20]  A. Shapiro,et al.  Rare bleeding disorders: diagnosis and treatment. , 2015, Blood.

[21]  A. Mangione,et al.  Pharmacokinetics and safety of plasma‐derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[22]  M. Callaghan,et al.  Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[23]  A. Mangione,et al.  Efficacy and safety of prophylactic treatment with plasma‐derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[24]  F. Peyvandi,et al.  Comparison of Thrombin Generation Assay With Conventional Coagulation Tests in Evaluation of Bleeding Risk in Patients With Rare Bleeding Disorders , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[25]  A. Mumford,et al.  Guideline for the diagnosis and management of the rare coagulation disorders , 2014, British journal of haematology.

[26]  S. Lukowski,et al.  FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations. , 2014, Thrombosis research.

[27]  S. Borrego,et al.  Experience of Preimplantation Genetic Diagnosis with HLA Matching at the University Hospital Virgen del Rocío in Spain: Technical and Clinical Overview , 2014, BioMed research international.

[28]  G. Mariani,et al.  Inhibitors to factor VII in congenital factor VII deficiency , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[29]  J. Griffin,et al.  Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant , 2014, Journal of thrombosis and haemostasis : JTH.

[30]  F. Peyvandi,et al.  Genetic sequence analysis of inherited bleeding diseases. , 2013, Blood.

[31]  F. Peyvandi,et al.  Rare Bleeding Disorders: Worldwide Efforts for Classification, Diagnosis, and Management , 2013, Seminars in Thrombosis & Hemostasis.

[32]  Bin Zhang,et al.  Combined Deficiency of Coagulation Factors V and VIII: An Update , 2013, Seminars in Thrombosis & Hemostasis.

[33]  A. Chuansumrit,et al.  Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER) , 2013, Haematologica.

[34]  R. Pruthi,et al.  Successful treatment with thalidomide of a patient with congenital factor V deficiency and factor V inhibitor with recurrent gastrointestinal bleeding from small bowel arteriovenous malformations , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[35]  G. Rodgers.  Prothrombin complex concentrates in emergency bleeding disorders , 2012, American journal of hematology.

[36]  F. Peyvandi,et al.  Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity , 2012, Journal of thrombosis and haemostasis : JTH.

[37]  A. Rivkind,et al.  Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery , 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[38]  B. George,et al.  Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[39]  G. Barillari,et al.  Whole blood rotation thromboelastometry (ROTEM®) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[40]  F. Rosendaal,et al.  Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders , 2012, Journal of thrombosis and haemostasis : JTH.

[41]  Christine A. Lee,et al.  Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. , 2011, European journal of obstetrics, gynecology, and reproductive biology.

[42]  E. Tuddenham,et al.  Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery , 2011, Thrombosis and Haemostasis.

[43]  F. Peyvandi,et al.  Prenatal diagnosis and preimplantation genetic diagnosis: novel technologies and state of the art of PGD in different regions of the world , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[44]  G. Pike,et al.  Factor deficiencies in pregnancy. , 2011, Hematology/oncology clinics of North America.

[45]  M. Borhany,et al.  Bleeding disorders in the tribe: result of consanguineous in breeding , 2010, Orphanet journal of rare diseases.

[46]  P. de Mazancourt,et al.  Thrombin generation in patients with factor XI deficiency and clinical bleeding risk , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[47]  M. El Sayed Zaki,et al.  Descriptive Epidemiology of Hemophilia and Other Coagulation Disorders in Mansoura, Egypt: Retrospective Analysis. , 2010, Mediterranean journal of hematology and infectious diseases.

[48]  G. Mariani,et al.  Hereditary combined deficiency of the vitamin K-dependent clotting factors , 2010, Orphanet journal of rare diseases.

[49]  A. James,et al.  Women and bleeding disorders , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[50]  D. Perry,et al.  A review of long‐term prophylaxis in the rare inherited coagulation factor deficiencies , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[51]  G. Kenet,et al.  Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[52]  I. Jaouad,et al.  Consanguineous marriages in Morocco and the consequence for the incidence of autosomal recessive disorders. , 2009, Journal of biosocial science.

[53]  U. Seligsohn,et al.  Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies , 2009, Thrombosis and Haemostasis.

[54]  A. Memon,et al.  Hereditary prothrombin deficiency. , 2009, JPMA. The Journal of the Pakistan Medical Association.

[55]  U. Seligsohn.  Factor XI deficiency in humans , 2009, Journal of thrombosis and haemostasis : JTH.

[56]  P. Mannucci,et al.  Introduction: Rare Bleeding Disorders: General Aspects of Clinical Features, Diagnosis, and Management , 2009, Seminars in thrombosis and hemostasis.

[57]  G. Mariani,et al.  Factor VII Deficiency , 2009, Seminars in thrombosis and hemostasis.

[58]  P. de Moerloose,et al.  Congenital Fibrinogen Disorders , 2009, Seminars in thrombosis and hemostasis.

[59]  J. Oldenburg,et al.  Vitamin K–Dependent Coagulation Factors Deficiency , 2009, Seminars in thrombosis and hemostasis.

[60]  F. Peyvandi,et al.  Combined Factor V and Factor VIII Deficiency. , 2009, Seminars in Thrombosis and Hemostasis.

[61]  P. Bolton-Maggs.  Factor XI deficiency--resolving the enigma? , 2009, Hematology. American Society of Hematology. Education Program.

[62]  S. Acharya,et al.  Rare inherited disorders of fibrinogen , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[63]  G. Mariani,et al.  Factor VII deficiency: defining the clinical picture and optimizing therapeutic options , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[64]  P. Monahan,et al.  Familial deficiency of vitamin K‐dependent clotting factors , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[65]  F. Peyvandi,et al.  National and international registries of rare bleeding disorders. , 2008, Blood transfusion = Trasfusione del sangue.

[66]  S. Adil,et al.  Frequency and clinical spectrum of rare inherited coagulopathies--a tricenter study. , 2008, JPMA. The Journal of the Pakistan Medical Association.

[67]  G. Davı̀,et al.  Inherited bleeding disorders: results from the Italian Regional Haemophilia Centre of Pescara. , 2008, Blood transfusion = Trasfusione del sangue.

[68]  M. Marietta,et al.  A web‐based registry of inherited bleeding disorders in the region of Emilia‐Romagna: results at three and a half years , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[69]  A. Girolami,et al.  Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[70]  M. Makris,et al.  Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy. , 2007, Blood transfusion = Trasfusione del sangue.

[71]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[72]  S. Pavord,et al.  The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors’ Organization , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[73]  P. Mannucci,et al.  Genetic diagnosis of haemophilia and other inherited bleeding disorders , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[74]  P. Monagle,et al.  Developmental haemostasis , 2006, Thrombosis and Haemostasis.

[75]  U. Seligsohn,et al.  Inhibitors to Factor XI in patients with severe Factor XI deficiency. , 2006, Seminars in hematology.

[76]  K. Wulff,et al.  Influence of Factor V HR2 on Thrombin Generation and Clinical Manifestation in Rare Bleeding Disorders , 2006, Pathophysiology of Haemostasis and Thrombosis.

[77]  Deborah L Brown.  Congenital bleeding disorders. , 2005, Current problems in pediatric and adolescent health care.

[78]  P. Mannucci,et al.  Recessively inherited coagulation disorders. , 2004, Blood.

[79]  M. Saadat,et al.  Short ReportConsanguineous marriage in Iran , 2004, Annals of human biology.

[80]  D. Dimichele,et al.  Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias , 2004, Journal of Thrombosis and Haemostasis.

[81]  D. Steinberg,et al.  Inherited factor XI deficiency confers no protection against acute myocardial infarction , 2003, Journal of thrombosis and haemostasis : JTH.

[82]  L. Muszbek,et al.  Coagulation Factor Deficiencies and Pregnancy Loss , 2003, Seminars in thrombosis and hemostasis.

[83]  C. Hermans,et al.  Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[84]  J. Abgrall,et al.  The use of recombinant factor VIIa (NovoSeven) in a patient with a factor XI deficiency and a circulating anticoagulant. , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[85]  M. Koh,et al.  Factor V inhibitor in neonatal intracranial hemorrhage secondary to severe congenital factor V deficiency. , 2001, Journal of pediatric hematology/oncology.

[86]  J. Abgrall,et al.  [Factor XI inhibitors : clinical and biological features]. , 2001, Annales de biologie clinique.

[87]  Bolton‐Maggs.  Factor XI deficiency and its management , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[88]  S. Antonarakis,et al.  Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia. , 2000, Blood.

[89]  F. Rosendaal,et al.  High levels of coagulation factor XI as a risk factor for venous thrombosis. , 2000, The New England journal of medicine.

[90]  Hann,et al.  Severe factor V deficiency and neonatal intracranial haemorrhage: a case report , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[91]  P. Mannucci,et al.  Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia , 1999, British journal of haematology.

[92]  F. Peyvandi,et al.  Symptoms of inherited factor V deficiency in 35 Iranian patients , 1998, British journal of haematology.

[93]  Mannucci,et al.  Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII , 1998, British journal of haematology.

[94]  A. Bener,et al.  CONSANGUINEOUS MARRIAGES IN THE UNITED ARAB EMIRATES , 1997, Journal of Biosocial Science.

[95]  M. Mittelman,et al.  The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. , 1997, Blood.

[96]  Muneera Al Bunyan,et al.  Consanguineous marriages in a Saudi population and the effect of inbreeding on prenatal and postnatal mortality , 1997 .

[97]  M. Andrew,et al.  The relevance of developmental hemostasis to hemorrhagic disorders of newborns. , 1997, Seminars in perinatology.

[98]  M. Samama,et al.  Familial Dysfibrinogenemia and Thrombophilia , 1995, Thrombosis and Haemostasis.

[99]  E. Davie,et al.  Factor XI deficiency in Ashkenazi Jews in Israel. , 1991, The New England journal of medicine.

[100]  G. Mariani,et al.  Inhibitor to factor V in severe factor V congenital deficiency. A case report. , 1985, Nouvelle revue francaise d'hematologie.

[101]  H. El-Tahan,et al.  Consanguineous matings in the Egyptian population. , 1983, Journal of medical genetics.